RxSight (RXST) Change in Account Payables (2020 - 2026)
RxSight posted quarterly Change in Account Payables of $1.6 million for Q1 2026, down 29.16% year-on-year from $2.2 million in Q1 2025, and down 28.45% on a QoQ basis from $2.2 million in Q4 2025.
RxSight (RXST) has 7 years of Change in Account Payables data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 29.16% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$22000.0 (down 101.1% YoY), and the FY2025 full-year result was $627000.0, down 33.72% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.6 million, down from $2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.2 million in Q1 2025 and bottomed at -$3.7 million in Q2 2025.
- The 5-year median for Change in Account Payables is $161000.0 (2023), against an average of $296176.5.
- The widest annual swing landed in 2022, when Change in Account Payables slumped 1779.21%; it then surged 1800.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$1.7 million in 2022, then surged by 90.68% to -$158000.0 in 2023, then soared by 173.42% to $116000.0 in 2024, then soared by 1800.0% to $2.2 million in 2025, then dropped by 28.45% to $1.6 million in 2026.
- The last three Change in Account Payables figures came in at $1.6 million (Q1 2026), $2.2 million (Q4 2025), and -$86000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | -86,000.00 |
| Sep 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | -387,000.00 |
| Jun 30, 2024 | -387,000.00 |
| Mar 31, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | -158,000.00 |
| Dec 31, 2023 | -158,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 1.16 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | -1.70 Mn |
| Dec 31, 2022 | -1.70 Mn |
| Sep 30, 2022 | 983,000.00 |
| Sep 30, 2022 | 983,000.00 |
| Jun 30, 2022 | 647,000.00 |
| Jun 30, 2022 | 647,000.00 |
| Mar 31, 2022 | 701,000.00 |
| Mar 31, 2022 | 701,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | -741,000.00 |
| Sep 30, 2021 | -741,000.00 |
| Jun 30, 2021 | 474,000.00 |
| Jun 30, 2021 | 474,000.00 |
| Mar 31, 2021 | 721,000.00 |
| Mar 31, 2021 | 721,000.00 |
| Dec 31, 2020 | -357,000.00 |
| Dec 31, 2020 | -357,000.00 |
| Sep 30, 2020 | -400,000.00 |
| Sep 30, 2020 | -400,000.00 |